Neasa Hourigan (Dublin Central, Green Party) | Oireachtas source

I will take a moment to talk about cancer genetics. I thank the Irish Cancer Society for its excellent briefing note. That was an interesting section to me. I am interested in the area. The overview the Irish Cancer Society gave was succinct and I thank the representatives for that. Cancer genetics in the future will be even more important because not only do they allow us to access particular patients, but they impact families and, therefore, bring a whole cohort of people into the system.

In the briefing note, the lack of a dedicated pathway for BRCA-positive patients was outlined. From the overview given, it seems we have no dedicated pathway for cancer genetics, no quality-assured screening for the service and no dedicated health teams to follow patients who have been identified. What plans are to be put in place in the next couple of years and how do they interact with Sláintecare?